Publicaciones en las que colabora con Francisco Santiago Lozano Sánchez (48)

2022

  1. Corrigendum

    Pain medicine (Malden, Mass.)

  2. New functions of C3G in platelet biology: Contribution to ischemia-induced angiogenesis, tumor metastasis and TPO clearance

    Frontiers in Cell and Developmental Biology, Vol. 10

2021

  1. Abdominal aortic aneurysm and acute appendicitis: a case report and review of the literature

    Journal of Medical Case Reports, Vol. 15, Núm. 1

  2. Early and late results of open surgical and endovascular treatment of infrarenal abdominal aortic aneurysms, selected according to surgical risk

    Jornal Vascular Brasileiro, Vol. 20

  3. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

    Trials, Vol. 22, Núm. 1

2020

  1. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)

    Frontiers in Immunology

  2. Decision-making and therapeutic options in intact splenic artery aneurysms: single-center experience and literature review

    International angiology : a journal of the International Union of Angiology, Vol. 39, Núm. 3, pp. 241-251

  3. Kinking graft—an exceptional late complication of axillofemoral bypass grafting

    Journal of Surgical Case Reports, Vol. 2020, Núm. 10

  4. Simple and complex carotid paragangliomas. Three decades of experience and literature review

    Head and Neck, Vol. 42, Núm. 12, pp. 3538-3550

  5. Spontaneous rupture of a mechanical valve in a mitral position (On-X) with migration-embolization to aortic bifurcation from the perspective of the vascular surgeon

    The Journal of cardiovascular surgery, Vol. 61, Núm. 2, pp. 256-263

  6. Superficial venous thrombosis is not a benign disease!

    Angiologia, Vol. 72, Núm. 3, pp. 135-144

  7. Transcaval access to the abdominal aorta: Indications of interest to surgeons and a comprehensive literature review

    Brazilian Journal of Cardiovascular Surgery, Vol. 35, Núm. 5, pp. 781-788

  8. Transdermal Buprenorphine for Controlling Pain in Patients with Critical Lower-Limb Ischemia

    Pain medicine (Malden, Mass.), Vol. 21, Núm. 5, pp. 1083-1085

  9. Venous thrombosis associated with venous compression syndromes

    Medicina Clinica, Vol. 154, Núm. 10, pp. 406-411

2019

  1. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus

    Frontiers in Immunology, Vol. 10, Núm. JUN

2018

  1. Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger's disease)

    Stem Cell Research and Therapy, Vol. 9, Núm. 1

2016

  1. Influence of UGT2B7, CYP3A4, and OPRM1 Gene Polymorphisms on Transdermal Buprenorphine Pain Control in Patients with Critical Lower Limb Ischemia Awaiting Revascularization

    Pain Practice, Vol. 16, Núm. 7, pp. 842-849

  2. Management patterns and outcomes in symptomatic venous thromboembolism following allogeneic hematopoietic stem cell transplantation. A 15-years experience at a single center

    Thrombosis Research, Vol. 142, pp. 52-56

  3. Questionários autoadministrados versus administrados por entrevistador para pacientes com claudicação intermitente: Os resultados são diferentes? Um estudo transversal

    Sao Paulo Medical Journal, Vol. 134, Núm. 1, pp. 63-69

2015

  1. Impact of cardiovascular risk factors on intermittent claudication

    Angiologia